Trade ATHE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Alterity Therapeutics Limited American Depositary Shares (ATHE) is trading at US$3.71, up 5.86% today as of Sep 16, 11:44 EDT. The company has a market capitalisation of US$84.65M. Over the past 52 weeks, ATHE has traded between US$2.66 and US$5.89. On Syfe you can trade ATHE with $0 commission and add it to your watchlist.
| Previous close | US$3.50 |
|---|---|
| Market cap | US$84.65M |
| 52-week range | US$2.66 – US$5.89 |
| Volume | 14.54K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Alterity Therapeutics Limited American Depositary Shares
Alterity Therapeutics Ltd. engages in the business of research and development of therapeutic drugs designed to treat neurodegenerative diseases, focusing on Parkinsonian and other movement disorders. Its lead candidate, ATH434, is an oral small molecule drug designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Year: 1992
Alterity Therapeutics Says FDA Backs Phase 3 Design for Multiple System Atrophy Therapy
Jul 7, 11:45 AM · MT Newswires
Stay on top of ATHE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
